⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL250855 | 1.00 | GNAI3 (0.70) | — | |
| SCHEMBL1043043 | 1.00 | GNAI3 (0.70) | — | |
| SCHEMBL18631049 | 0.97 | GNAI3 (0.74) | — | |
| SCHEMBL4307534 | 0.97 | GNAI3 (0.74) | — | |
| SCHEMBL11569527 | 0.97 | GNAI3 (0.74) | — | |
| SCHEMBL6057505 | 0.97 | GNAI3 (0.74) | — | |
| SCHEMBL6550696 | 0.97 | GNAI3 (0.74) | — | |
| SCHEMBL18630767 | 0.97 | GNAI3 (0.74) | — | |
| SCHEMBL8536145 | 0.97 | GNAI3 (0.74) | — | |
| SCHEMBL8575694 | 0.97 | GNAI3 (0.74) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 407 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113200901-A | Aziridine-2-yl- (aryl) ketone derivative and preparation method thereof | 上海应用技术大学 | 2021-08-03 | — | — | CN | claimed |
| US-20160220694-A1 | Vitamin-Receptor Binding Drug Delivery Conjugates | ENDOCYTE INC (US) | 2016-08-04 | — | — | US | claimed |
| EP-2931790-A1 | ACTINICALLY-CROSSLINKABLE AMPHIPHILIC PREPOLYMERS | Novartis AG (CH) | 2015-10-21 | — | — | EP | claimed |
| US-8765982-B2 | Synergistic anticoagulant composition | MARSHFIELD CLINIC HEALTH SYSTEM, INC. (US) | 2014-07-01 | — | — | US | claimed |
| WO-2014093756-A1 | ACTINICALLY-CROSSLINKABLE AMPHIPHILIC PREPOLYMERS | NOVARTIS AG (CH) | 2014-06-19 | — | — | WO | claimed |
| EP-1948241-B1 | MULTI-DRUG LIGAND CONJUGATES | ENDOCYTE INC (US) | 2014-03-05 | — | — | EP | claimed |
| US-8486534-B2 | Surface-modified polymer films | BAR-ILAN UNIVERSITY (IL) | 2013-07-16 | — | — | US | claimed |
| EP-2470616-B1 | ACRYLIC PRESSURE-SENSITIVE ADHESIVES WITH ACYLAZIRIDINE CROSSLINKING AGENTS | 3M INNOVATIVE PROPERTIES CO (US) | 2013-05-29 | — | — | EP | claimed |
| US-20130053508-A1 | ACRYLIC PRESSURE-SENSITIVE ADHESIVES WITH ACYLAZIRIDINE CROSSLINKING AGENTS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2013-02-28 | — | — | US | claimed |
| US-20120234196-A1 | Viscous Liquid Monopropellant | PLANETARY SYSTEMS CORPORATION | 2012-09-20 | — | — | US | claimed |
| EP-1948240-A2 | LIGAND CONJUGATES OF VINCA ALKALOIDS, ANALOGS AND DERIVATIVES | Endocyte, Inc. (US) | 2008-07-30 | — | — | EP | claimed |
| EP-1948241-A2 | MULTI-DRUG LIGAND CONJUGATES | Endocyte, Inc. (US) | 2008-07-30 | — | — | EP | claimed |
| WO-2007022493-A2 | LIGAND CONJUGATES OF VINCA ALKALOIDS, ANALOGS, AND DERIVATIVES | ENDOCYTE, INC. (US) | 2007-02-22 | — | — | WO | claimed |
| WO-2007022494-A2 | MULTI-DRUG LIGAND CONJUGATES | ENDOCYTE, INC. (US) | 2007-02-22 | — | — | WO | claimed |
| EP-1592457-A2 | VITAMIN RECEPTOR BINDING DRUG DELIVERY CONJUGATES | Endocyte, Inc. (US) | 2005-11-09 | — | — | EP | claimed |
| US-20050002942-A1 | Minimized toxicity; eliminating pathogenic cell populations; synthesis; claimed intermediates | ENDOCYTE, INC. | 2005-01-06 | — | — | US | claimed |
| WO-2004069159-A2 | VITAMIN RECEPTOR BINDING DRUG DELIVERY CONJUGATES | ENDOCYTE, INC. (US) | 2004-08-19 | — | — | WO | claimed |
| EP-1289732-A1 | COMPRESSION INJECTION MOLDING PROCESS | remaplan Anlagenbau GmbH (DE) | 2003-03-12 | — | — | EP | claimed |
| WO-2001091988-A1 | METHOD FOR COMPRESSION MOULDING A MOULDED BODY | REMAPLAN ANLAGENBAU GMBH (DE) | 2001-12-06 | — | — | WO | claimed |
| US-4147870-A | REACTION OF ACYLAZIRIDINE WITH MONOSULFONYL DERIVATIVE OF PIPERAZINE | LABORATORIOS LIADE, S.A. (ES) | 1979-04-03 | — | — | US | claimed |